Can a quick ultrasound spot a deadly lung complication in sickle cell kids?

NCT ID NCT06880679

Recruiting now Diagnosis Sponsor: Indiana University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether a bedside ultrasound (POCUS) can help doctors quickly diagnose acute chest syndrome in children and young adults with sickle cell disease. Researchers will enroll 30 hospitalized patients aged 0-25 to see if the ultrasound is practical and reliable compared to standard chest X-rays. The goal is to find a faster, safer way to detect this serious lung complication.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Point-of-care ultrasound (POCUS) device
What this could lead to: If successful, this could make diagnosing acute chest syndrome faster and easier, potentially improving outcomes for sickle cell patients.
What could go wrong: This is a small, early feasibility study with only 30 participants. The ultrasound may not be as reliable as standard chest X-rays, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE CHEST SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute chest syndrome sickle cell disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE CHEST SYNDROME SICKLE CELL DISEASE

Contacts and locations

Locations

Indiana University
RECRUITING

Indianapolis, Indiana, 46202, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.